Wearable-Based Monitoring of Autonomic and Gastrointestinal Function in Disorders of Gut-Brain Interaction: A Systematic Review and Meta-Analyses.

Fleur Veldman, Michelle Bosman, Ali Rezaie, Sarvee Moosavi, Daniel Keszthelyi

Journal: Neurogastroenterology and motility 2026;38(1):e70232

PMID: 41553708

Abstract

BACKGROUND

Autonomic nervous system (ANS) activity is implicated in the pathogenesis of disorders of gut-brain interaction (DGBI). Technological advances enable more accurate investigation of ANS function.

AIM

This study aimed to evaluate the clinical utility of wearable devices in monitoring autonomic and gastrointestinal (GI) function in DGBI.

METHODS

A systematic search identified studies in adults with DGBI using wearables to assess heart rate variability (HRV), sleep, skin conductance, or gastric myoelectric activity as clinical readouts for ANS and GI function. The review provides an overview of available devices, while the meta-analysis evaluates consistency in detecting differences between DGBI and healthy controls (HCs). Associations between autonomic function and GI symptom severity were explored. Methodological quality was assessed using the Cochrane risk of bias tool and ROBINS-I. Meta-analyses used random-effects models with standardized mean differences (SMDs).

RESULTS

Thirty-six studies (3 RCTs, 33 observational) involving 3986 DGBI patients were included (HRV: n = 16, sleep: n = 7, gastric myoelectric activity: n = 14, skin conductance: n = 0). Meta-analyses showed lower Root Mean Square of Successive Differences (SMD = -0.503, SE 0.189, 95% CI [-0.873, -0.132]) and percentage of successive RR intervals differing by > 50 ms (SMD = -0.430, SE 0.176, 95% CI [-0.775, -0.085]), reflecting HRV alterations in DGBI versus HCs. No consistent differences were found for other metrics, except normal gastric slow waves (SMD = -0.722, SE 0.216, 95% CI [-1.146, -0.298]). Heterogeneous ANS-symptom associations precluded definitive conclusions.

CONCLUSIONS

Wearables show potential for detecting altered ANS and GI function in DGBI, particularly via HRV. Result variability highlights need for further research to confirm accuracy and clinical utility.

© 2026 The Author(s). Neurogastroenterology & Motility published by John Wiley & Sons Ltd.

Address: Department of Gastroenterology-Hepatology, NUTRIM Research Institute of Nutrition and Translational Research in Metabolism, Maastricht University Medical Center, Maastricht, the Netherlands.; GI Motility Program, Division of Gastroenterology, Department of Medicine, Cedars-Sinai, Los Angeles, California, USA.; Neurogastroenterology & GI Motility, Department of Gastroenterology, University of British Columbia, Vancouver, Canada.
Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.